Bonus episode: Today we’re bringing you the latest episode of Bold Names, which presents conversations with the leaders of the bold-named companies featured in the pages of The Wall Street Journal. On this episode, hosts Tim Higgins and Christopher Mims speak to Michael Mager, co-founder and CEO of the brain-computer interface company Precision Neuroscience, whose technology aims to give patients with severe mobility issues new ways to interact with the digital world. How does Precision plan to offer brain implants to millions of people who could benefit from them? And how is the company competing with rivals like Synchron and Elon Musk’s Neuralink?

Listen and subscribe to Bold Names. 

Learn more about your ad choices. Visit megaphone.fm/adchoices